The U of M and Mayo Clinic recently announced three collaborative research grants totaling $5.82 million through the Minnesota Partnership for Biotechnology and Medical Genomics. The initiative provides funding and support for the development of interventions, programs, and treatment approaches across the entire spectrum of biomedical and health care research with the ultimate goal of improving health outcomes for Minnesotans. This year’s award recipients are:
Theoden Netoff, PhD, UMN; Gregory Worrell, MD, PhD, Mayo Clinic; Alex Opitz, PhD, UMN; Paul Croarkin, DO, MS, Mayo Clinic
Minnesota Precision Neuromodulation Center (MinPeNCe)
Genevieve Melton-Meaux, MD, PhD, UMN; Pedro Caraballo, MD, Mayo Clinic; Gyorgy Simon, PhD, UMN; Hongfang Liu, PhD, Mayo Clinic
ENTRUST AI: ENsuring the TRUSTworthiness of AI/ML Models to Optimize Continual Patient Safety
Bruce Blazar, MD, UMN; Saad Kenderian, MD, ChB, Mayo Clinic
Targeting CD103 with Engineered Cell Therapy for the Treatment of GVHD
